Dr. Brett E. Stanaland, MD

Dr. Stanaland practices at Brett E. Stanaland, M.D., P.A. in Naples, Florida.

Dr. Stanaland's NPI, 1508865924, was assigned on July 18, 2005. Dr. Stanaland graduated from USF Health Morsani College of Medicine in 1989. Dr. Stanaland holds Florida license ME0062874.

Dr. Stanaland's primary practice is Brett E. Stanaland, M.D., P.A., at 1000 Goodlette N Rd, Naples, FL 34102 in Collier County. The practice phone is (239) 434-6200.

Dr. Stanaland's primary practice is Brett E. Stanaland, M.D., P.A. in Naples, Florida. Dr. Stanaland is also affiliated with NCH Baker Hospital. The medical group on file is Allergy, Sinus & Asthma Specialists of Naples. Dmand AI also links Dr. Stanaland to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stanaland practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Stanaland's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Stanaland is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Stanaland's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Stanaland treats.

CMS data shows 88,070 Medicare services from Dr. Stanaland across 20 procedure codes in 2024, for 1,436 Medicare patients. Medicare paid $1,569,960 for them. Every service was in an office.

CMS counts 1,436 Medicare patients who saw Dr. Stanaland in 2024. The largest group is 75 to 84, with 669 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stanaland's median patient age at 64, with 64% women.

In 2024, Dr. Stanaland wrote 4,786 Medicare Part D claims for 1,068 patients. 75% of them were for generic drugs. CMS names the drug for 4,604 of them, across 44 drugs with 11 or more claims each, at $1,381,596 in total drug cost. In 2023, CMS named 4,908 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Stanaland for performance year 2024, reported as part of a group. Dr. Stanaland accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Stanaland. The most frequent topics are Cross Reactions, Radioallergosorbent Test and Allergens. Dr. Stanaland has published most often in Int Arch Allergy Appl Immunol. Dr. Stanaland's most frequent co-authors are Carlos M. Jacinto, MD and Richard F. Lockey, MD.

CMS Open Payments shows 1,163 general payments to Dr. Stanaland from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. GlaxoSmithKline, LLC. paid the most, $331,927.

Dmand AI lists 5 awards for Dr. Stanaland, most recently Gulfshore Life Magazine: Top Doctors in 2014.

Dr. Stanaland graduated from USF Health Morsani College of Medicine in 1989. Dr. Stanaland is a member of AAAAI.

Dr. Stanaland is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.